Sara Majocchi
Light Chain Bioscience is very pleased to have Sara Majocchi, PhD, Discovery Program Leader, speaking at the Keystone Symposium on “Next Generation Antibody Therapeutics: From Discovery to Patient”
Sara will talk about “Tumor and Immune Checkpoint-Dependent CD28 Agonism Using Bispecific Antibodies” as part of the “Emerging Costimulatory Therapies in Oncology” session on Tuesday, February 21 @ 18:30 MST.
19-22 February 2023
Fairmont Banff Spring, Banff, Canada
